Although galectin-3 is predominantly expressed by activated macrophages and a promising biomarker for patients with heart failure, it does not appear to affect the survival, systolic and diastolic dysfunction, cardiac fibrosis, and cardiomyocyte hypertrophy in the pressure-overloaded heart 51. The gene discussed is LGALS3; the disease is heart failure.